U.S. Stock Insider Trading | The Oncology disclosed details of three insider trading transactions on March 17

robot
Abstract generation in progress

On March 17, 2026, The Oncology (TOI) disclosed three instances of company insider trading. Shareholder Chernett Jorey, who holds more than 10%, bought 263,000 shares on March 17, 2026.

【Recent Insider Transactions】

Disclosure date Position Name Transaction date Buy/Sell Quantity Price per share/USD Total amount/USD
March 17, 2026 Shareholder holding more than 10% Chernett Jorey March 17, 2026 Buy 75,000 3.42 256,500
March 17, 2026 Shareholder holding more than 10% Chernett Jorey March 16, 2026 Buy 61,000 3.29 200,600
March 17, 2026 Shareholder holding more than 10% Chernett Jorey March 13, 2026 Buy 263,000 2.92 768,000
January 6, 2026 Executive Carter Robert Ross January 2, 2026 Sell 244 3.67 895.48
December 16, 2025 Director Hively Brad December 15, 2025 Sell 13,300 3.77 50,300
November 20, 2025 Director Pacala Mark L November 18, 2025 Sell 50,000 4.00 200,000
September 5, 2025 Shareholder holding more than 10% M33 Growth I L.P. September 4, 2025 Sell 6,700,000 3.09 20,703,000
August 21, 2025 Director Hively Brad August 19, 2025 Sell 20,200 4.06 82,100
June 24, 2025 Director BARASCH RICHARD A June 17, 2025 Buy 679,200 1.20 813,700
June 24, 2025 Director BARASCH RICHARD A June 17, 2025 Sell 311,100 2.62 813,700

【Company Profile】

The Oncology Institute, Inc. is a Delaware company founded on November 1, 2019. The company is a leading value-based oncology company, managing community-based oncology practices and serving patients at 76 clinics across 15 markets and 5 states in the United States. The company operates community-based oncology clinics staffed by 112 oncology physicians and advanced practice providers. Among these clinics, 62 clinics are equipped with 101 medical personnel, who are employed by its affiliated, physician-owned professional companies, known as “TOI personal computers.” The clinics managed by the company provide a range of oncology medical services, including physician services, in-house infusion and pharmacy, clinical trial services, radiology, and innovative programs such as outpatient blood product transfusions, as well as around-the-clock patient support.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments